K J Ruddy

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi request reprint Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship
    K J Ruddy
    Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Ann Oncol 24:1434-43. 2013
  2. pmc Long-term risk perceptions of women with ductal carcinoma in situ
    Kathryn J Ruddy
    Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    Oncologist 18:362-8. 2013
  3. pmc Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)
    K J Ruddy
    Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Ann Oncol 23:3075-81. 2012
  4. doi request reprint Quality of life and symptoms in male breast cancer survivors
    Kathryn J Ruddy
    Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    Breast 22:197-9. 2013
  5. doi request reprint Patient adherence and persistence with oral anticancer treatment
    Kathryn Ruddy
    Department of Breast Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, MA 02115, USA
    CA Cancer J Clin 59:56-66. 2009
  6. ncbi request reprint Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls
    Kathryn J Ruddy
    Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Menopause 18:105-8. 2011
  7. doi request reprint Genetic testing in young women with breast cancer: results from a Web-based survey
    K J Ruddy
    Department of Adult Oncology, Breast Oncology Center, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Ann Oncol 21:741-7. 2010
  8. ncbi request reprint Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer
    K J Ruddy
    Dana Farber Cancer Institute, Boston, MA Massachusetts General Hospital, Boston, MA Brigham and Women s Hospital, Boston, MA
    J Clin Oncol 26:9571. 2008
  9. ncbi request reprint Presentation of breast cancer in young women
    K J Ruddy
    Dana Farber Cancer Institute, Boston, MA Brigham and Women s Hospital, Boston, MA Massachusetts General Hospital, Boston, MA Beth Israel Deaconess Medical Center, Boston, MA
    J Clin Oncol 27:6608. 2009
  10. ncbi request reprint Fertility concerns in young women with breast cancer: Results from a prospective cohort study
    K J Ruddy
    Dana Farber Cancer Institute, Boston, MA Brigham and Women s Hospital, Boston, MA Massachusetts General Hospital, Boston, MA Beth Israel Deaconess Medical Center, Boston, MA
    J Clin Oncol 29:6025. 2011

Detail Information

Publications10

  1. doi request reprint Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship
    K J Ruddy
    Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Ann Oncol 24:1434-43. 2013
    ..The causes, optimal treatments, and medical/psychosocial sequelae of breast cancer in men are poorly understood...
  2. pmc Long-term risk perceptions of women with ductal carcinoma in situ
    Kathryn J Ruddy
    Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    Oncologist 18:362-8. 2013
    ..This study aims to evaluate risk perceptions after 5 years...
  3. pmc Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)
    K J Ruddy
    Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Ann Oncol 23:3075-81. 2012
    ..We sought to measure persistence with CMF, adherence to oral cyclophosphamide, and the association of these with toxic effects...
  4. doi request reprint Quality of life and symptoms in male breast cancer survivors
    Kathryn J Ruddy
    Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    Breast 22:197-9. 2013
    ..Little is known about quality of life and symptoms of male breast cancer survivors...
  5. doi request reprint Patient adherence and persistence with oral anticancer treatment
    Kathryn Ruddy
    Department of Breast Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, MA 02115, USA
    CA Cancer J Clin 59:56-66. 2009
    ..Studies that included educational, behavioral, and multidimensional interventions to improve adherence were also described...
  6. ncbi request reprint Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls
    Kathryn J Ruddy
    Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Menopause 18:105-8. 2011
    ..However, there has been little research to date comparing young survivors’ concerns and symptoms with those of young women of the same age and gravidity in the general population...
  7. doi request reprint Genetic testing in young women with breast cancer: results from a Web-based survey
    K J Ruddy
    Department of Adult Oncology, Breast Oncology Center, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Ann Oncol 21:741-7. 2010
    ..Young women with breast cancer have an increased risk for harboring a BRCA1 or BRCA2 mutation. Frequency of genetic testing and factors associated with testing have not been well described in this population...
  8. ncbi request reprint Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer
    K J Ruddy
    Dana Farber Cancer Institute, Boston, MA Massachusetts General Hospital, Boston, MA Brigham and Women s Hospital, Boston, MA
    J Clin Oncol 26:9571. 2008
    ..Ovarian reserve testing predicts response to fertility treatments, but to date has not been well studied in women exposed to chemotherapy...
  9. ncbi request reprint Presentation of breast cancer in young women
    K J Ruddy
    Dana Farber Cancer Institute, Boston, MA Brigham and Women s Hospital, Boston, MA Massachusetts General Hospital, Boston, MA Beth Israel Deaconess Medical Center, Boston, MA
    J Clin Oncol 27:6608. 2009
    ..Furthermore, a lower suspicion for malignancy in this population may cause diagnostic delays. It is unknown how much the lack of routine screening and potential diagnostic delays contribute to the poorer outcomes of younger women...
  10. ncbi request reprint Fertility concerns in young women with breast cancer: Results from a prospective cohort study
    K J Ruddy
    Dana Farber Cancer Institute, Boston, MA Brigham and Women s Hospital, Boston, MA Massachusetts General Hospital, Boston, MA Beth Israel Deaconess Medical Center, Boston, MA
    J Clin Oncol 29:6025. 2011
    ..We sought to evaluate fertility issues in the setting of an ongoing multicenter cohort study of young women with newly diagnosed breast cancer...